209 related articles for article (PubMed ID: 1610026)
1. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
[TBL] [Abstract][Full Text] [Related]
2. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
4. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
Arkinstall WW; Atkins ME; Harrison D; Stewart JH
Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
[TBL] [Abstract][Full Text] [Related]
5. Assessing the efficacy and safety of q. d. theophylline therapy: a multicenter study.
Dockhorn RJ; Green AW; Green E
Ann Allergy; 1985 Nov; 55(5):658-64. PubMed ID: 2865917
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
7. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations.
Karttunen P; Tukiainen H; Nykänen S; Saano V
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302
[TBL] [Abstract][Full Text] [Related]
8. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
[TBL] [Abstract][Full Text] [Related]
9. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
10. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
11. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of theophylline chronokinetics for asthmatic children.
Smolensky MH; Scott PH; McGovern JP
Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
[TBL] [Abstract][Full Text] [Related]
13. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients.
Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
16. Once daily Theo-Dur in morning dippers.
van der Vet AP; Quaedvlieg M; Greve LH
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):258-64. PubMed ID: 3410602
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of sustained-released theophylline on peak expiratory flow rate in asthmatic patients].
Yoshimine F; Sasagawa M; Kon Y; Yamaguchi S; Suzuki E; Gejyo F
Arerugi; 2000 Jul; 49(7):593-9. PubMed ID: 10944826
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]